Singapore Grants Patent for babyLance Infant Heel Incision Device

Launched last July, babyLance is a single-use heel incision device utilized to obtain a blood sample from the heels of newborn (babyLance BLN) and preemie (babyLance BLP) infants.
April 21, 2011 - PRLog -- SINGAPORE and ATLANTA – MediPurpose, a master distributor and manufacturer of medical products, today announced an addition to its expanding portfolio of medical device patents.

MediPurpose recently received approval of its application for patent protection of its babyLance infant heel incision device from the Intellectual Property Office of Singapore.

The IPOS issued MediPurpose a Certificate of Grant of Patent number 167188.
The infant heel incision device's patent approval is currently pending in several other countries.

Launched last July, babyLance is a single-use heel incision device utilized to obtain a blood sample from the heels of newborn (babyLance BLN) and preemie (babyLance BLP) infants.

The IPOS patent protects the unique design of the babyLance(tm) infant heel incision device, which earned it a U.S. Food and Drug Administration 510(k) clearance with sharps prevention indications-the first infant heel stick to earn such a distinction. These sharps prevention indications include:

   * A locking mechanism to prevent accidental activation of the device.

   * A housing that conceals the blade before and after the device is used.

   * An internal spring that automatically retracts the blade after use.

   * A stop feature that disables the device after a single use.

Although perhaps best known for the manufacture and distribution of its popular medical devices, MediPurpose offers product development and distribution services through its Medical Device Innovation and Medical Product Distribution divisions.

More information about babyLance--including demonstration videos and no-cost product sample requests--is available at

# # #

About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.

Known for its popular SurgiLance safety lancet, babyLance heel incision device and MediPlus advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.

MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.

For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit
Source:Derek Rudnak | MediPurpose®
Email:*** Email Verified
Tags:Medipurpose, Babylance, Singapore, Patent, Medical Device, Medical Product, Neonatal, Infant, Heel Stick, Incision
Industry:Business, Health, Medical
Location:Duluth - Georgia - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Aug 15, 2011
babyLance™ Safety Heelsticks News
Daily News
Weekly News

Like PRLog?
Click to Share